Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $90.3600 (1.44%) ($88.5100 - $91.1800) on Wed. Feb. 17, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.83% (three month average) | RSI | 36 | Latest Price | $90.3600(1.44%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.2% a day on average for past five trading days. | Weekly Trend | LGND declines -6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(56%) XBI(56%) IWC(52%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.415% in a week (0% probabilities). VIXM(-16%) TLT(-16%) UUP(-7%) GDXJ(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.415% (StdDev 2.83%) | Hourly BBV | 0 () | Intraday Trend | 0.7% | | | |
|
1 - 5 Day Possible Target | $78.32(-13.32%) | Resistance Level | $95.34 | 5 Day Moving Average | $87.89(2.81%) | 10 Day Moving Average | $90.82(-0.51%) | 20 Day Moving Average | $95.34(-5.22%) | To recent high | -19.2% | To recent low | 5.3% | Market Cap | $1.452b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |